GDOCvsIHEETF Comparison
Goldman Sachs Future Health Care Equity ETF (GDOC) belongs to the Healthcare Technology segment. iShares U.S. Pharmaceuticals ETF (IHE) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. GDOC is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.38% for IHE. GDOC is down -9.96% year-to-date (YTD) with +$2M in YTD flows. IHE performs better with 5.78% YTD performance, and +$1M in YTD flows. Run a side-by-side ETF comparison of GDOC and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
GDOC vs IHE performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GDOC IHE | -2.65%+3.49% | -9.35%+1.49% | -9.96%+5.78% | +2.80%+37.20% | -2.42%+54.18% | n/a+62.24% |
| Flows | GDOC IHE | --$127M | +$2M-$109M | +$2M+$1M | +$920K+$135M | -$77M+$232M | -+$265M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GDOC IHE | +17.08%+18.44% | +14.78%+17.64% | +14.41%+16.24% | n/a+16.05% |
| Max drawdown | GDOC IHE | -11.30%-8.48% | -15.39%-8.48% | -22.18%-16.04% | n/a-16.12% |
| Max drawdown duration | GDOC IHE | 88d65d | 155d65d | 449d210d | n/a669d |
GDOC | IHE | |
Last sale 5/5/2026 at 1:30 PM | $32.29 | $89.33 |
| Previous close 05/05/2026 | $32.13 | $88.43 |
| Consolidated volume 05/05/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
GDOC | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
GDOC | IHE | |
|---|---|---|
| Last price | $32.29 | $89.33 |
| 1D performance | +0.52% | +1.02% |
| AuM | $20.85 M | $898.23 M |
| E/R | 0.75% | 0.38% |
GDOC | IHE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Goldman Sachs | iShares |
| Benchmark | - | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 33 | 45 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 11, 2021 | May 1, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
